CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- S-8 Other Securities Offered to Employees in Benefit Plans
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- S-3ASR Offering Registration Statement
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- D Other Notice of Sales of Unregistered Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
Page 1 of 7 · 127 filings